tiprankstipranks
Trending News
More News >
Strategic Workforce Restructuring and Clinical Advancements Justify Buy Rating for Korro Bio
PremiumRatingsStrategic Workforce Restructuring and Clinical Advancements Justify Buy Rating for Korro Bio
2M ago
Korro Bio reports Q1 EPS ($2.49), consensus ($2.62)
Premium
The Fly
Korro Bio reports Q1 EPS ($2.49), consensus ($2.62)
2M ago
Korro Bio Announces Strategic Workforce Reduction Plan
Premium
Company Announcements
Korro Bio Announces Strategic Workforce Reduction Plan
2M ago
Korro Bio CFO Returns from Medical Leave
PremiumCompany AnnouncementsKorro Bio CFO Returns from Medical Leave
3M ago
Korro Bio Reports 2024 Financial Results and Progress
Premium
Company Announcements
Korro Bio Reports 2024 Financial Results and Progress
4M ago
Korro Bio price target lowered to $95 from $105 at RBC Capital
Premium
The Fly
Korro Bio price target lowered to $95 from $105 at RBC Capital
4M ago
Korro Bio Appoints Interim CFO Amid Medical Leave
PremiumCompany AnnouncementsKorro Bio Appoints Interim CFO Amid Medical Leave
5M ago
Korro Bio announces initiation of dosing in its REWRITE study on KRRO-110
Premium
The Fly
Korro Bio announces initiation of dosing in its REWRITE study on KRRO-110
6M ago
Korro initiated with Outperform into 2025 catalysts at Oppenheimer
Premium
The Fly
Korro initiated with Outperform into 2025 catalysts at Oppenheimer
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100